BioXcel Therapeutics: Outpatient Trial Expected to Enroll About 200 Patients With Agitation Associated With Bipolar Disorder or Schizophrenia
BioXcel Therapeutics:門診試驗預計將招收約200名與躁鬱症或精神分裂症相關的焦慮症患者
BioXcel Therapeutics: Outpatient Trial Expected to Enroll About 200 Patients With Agitation Associated With Bipolar Disorder or Schizophrenia
BioXcel Therapeutics:門診試驗預計將招收約200名與躁鬱症或精神分裂症相關的焦慮症患者
使用瀏覽器的分享功能,分享給你的好友吧